Tissue-specificity of heparan sulfate biosynthetic machinery in cancer

作者: Anastasia V Suhovskih , Natalya V Domanitskaya , Alexandra Y Tsidulko , Tatiana Y Prudnikova , Vladimir I Kashuba

DOI: 10.1080/19336918.2015.1049801

关键词:

摘要: Heparan sulfate (HS) proteoglycans are key components of cell microenvironment and fine structure their polysaccharide HS chains plays an important role in cell-cell interactions, adhesion, migration signaling. It is formed on non-template basis, so, functional activity biosynthetic machinery crucial for correct biosynthesis post-synthetic modification. To reveal cancer-related changes transcriptional pattern system, the expression metabolism-involved genes (EXT1/2, NDST1/2, GLCE, 3OST1/HS3ST1, SULF1/2, HPSE) human normal (fibroblasts, PNT2) cancer (MCF7, LNCaP, PC3, DU145, H157, H647, A549, U2020, U87, HT116, KRC/Y) lines breast, prostate, colon tumors was studied. Real-time RT-PCR Western-blot analyses revealed specific patterns levels system both different vitro cancers vivo. Balance between activities elongation- modification- involved suggested as most informative parameter characterization. Normal fibroblasts showed elongation-oriented biosynthesis, while PNT2 prostate epithelial cells had modification-oriented one. However, demonstrated common tendency to acquire fibroblast-like mode system. Surprisingly, aggressive metastatic (U2020, retained similar cells, possibly enabling keep like-to-normal surface glycosylation escape antimetastatic control. The obtained results show type-specific HS-biosynthetic tissue-specific vivo, supporting a close involvement carcinogenesis.

参考文章(43)
Uri Barash, Victoria Cohen-Kaplan, Ilana Dowek, Ralph D. Sanderson, Neta Ilan, Israel Vlodavsky, Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS Journal. ,vol. 277, pp. 3890- 3903 ,(2010) , 10.1111/J.1742-4658.2010.07799.X
Nikos Afratis, Chrisostomi Gialeli, Dragana Nikitovic, Theodore Tsegenidis, Evgenia Karousou, Achilleas D Theocharis, Mauro S Pavão, George N Tzanakakis, Nikos K Karamanos, None, Glycosaminoglycans: key players in cancer cell biology and treatment FEBS Journal. ,vol. 279, pp. 1177- 1197 ,(2012) , 10.1111/J.1742-4658.2012.08529.X
Beleford D, Khurana A, Chien J, He X, Shridhar, Role of heparan sulfatases in ovarian and breast cancer. American Journal of Cancer Research. ,vol. 3, pp. 34- 45 ,(2013)
Olga M.S. Toledo, Carl P. Dietrich, Tissue specific distribution of sulfated mucopolysaccharides in mammals. Biochimica et Biophysica Acta. ,vol. 498, pp. 114- 122 ,(1977) , 10.1016/0304-4165(77)90092-7
J. Presto, M. Thuveson, P. Carlsson, M. Busse, M. Wilen, I. Eriksson, M. Kusche-Gullberg, L. Kjellen, Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 4751- 4756 ,(2008) , 10.1073/PNAS.0705807105
Hiroshi Nakato, Koji Kimata, Heparan sulfate fine structure and specificity of proteoglycan functions. Biochimica et Biophysica Acta. ,vol. 1573, pp. 312- 318 ,(2002) , 10.1016/S0304-4165(02)00398-7
Catherine Bui, Mohamed Ouzzine, Ibtissam Talhaoui, Sheila Sharp, Kristian Prydz, Michael W. H. Coughtrie, Sylvie Fournel‐Gigleux, Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells The FASEB Journal. ,vol. 24, pp. 436- 450 ,(2010) , 10.1096/FJ.09-136291
Olivia García-Suárez, Beatriz García, Iván Fernández-Vega, Aurora Astudillo, Luis M. Quirós, Neuroendocrine Tumors Show Altered Expression of Chondroitin Sulfate, Glypican 1, Glypican 5, and Syndecan 2 Depending on Their Differentiation Grade Frontiers in Oncology. ,vol. 4, pp. 15- 15 ,(2014) , 10.3389/FONC.2014.00015
Sheng-Tai Tzeng, Ming-Hong Tsai, Chi-Long Chen, Jing-Xing Lee, Tzu-Ming Jao, Sung-Liang Yu, Sou-Jhy Yen, Ya-Chien Yang, NDST4 Is a Novel Candidate Tumor Suppressor Gene at Chromosome 4q26 and Its Genetic Loss Predicts Adverse Prognosis in Colorectal Cancer PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0067040
N. J. Nasser, Heparanase involvement in physiology and disease Cellular and Molecular Life Sciences. ,vol. 65, pp. 1706- 1715 ,(2008) , 10.1007/S00018-008-7584-6